Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Clobazam since 2013?

What pharmacies pay, not what you pay. Clobazam has 3 products in the CMS NADAC survey, 3 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Clobazam 10 MG Tablet: $0.515 per unit at the 2019 survey and $0.244 at 2026 (−53%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Clobazam3 products in NADAC
3products with a price history
  1. Clobazam has 3 products in the CMS NADAC survey, 3 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 3 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Clobazam 10 MG Tablet

Generic

$0.515 per unit at the 2019 year-end survey (14 NDCs) and $0.244 at the 2026 survey (9 NDCs): −53%.

$0$0.5152019: median $0.515 per unit, 14 NDCs priced2020: median $0.363 per unit, 16 NDCs priced2021: median $0.300 per unit, 16 NDCs priced2022: median $0.368 per unit, 14 NDCs priced2023: median $0.353 per unit, 12 NDCs priced2024: median $0.240 per unit, 10 NDCs priced2025: median $0.257 per unit, 10 NDCs priced2026: median $0.244 per unit, 9 NDCs priced20192020202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2019 (2019-12-25)$0.51514
2020 (2020-12-30)$0.36316
2021 (2021-12-29)$0.30016
2022 (2022-12-28)$0.36814
2023 (2023-12-27)$0.35312
2024 (2024-12-25)$0.24010
2025 (2025-12-31)$0.25710
2026 (2026-11-11)$0.2449

Clobazam 2.5 MG/ML Suspension

Generic

$0.703 per mL at the 2019 year-end survey (7 NDCs) and $0.182 at the 2026 survey (7 NDCs): −74%.

$0$0.7032019: median $0.703 per mL, 7 NDCs priced2020: median $0.559 per mL, 8 NDCs priced2021: median $0.607 per mL, 10 NDCs priced2022: median $0.316 per mL, 11 NDCs priced2023: median $0.239 per mL, 9 NDCs priced2024: median $0.229 per mL, 8 NDCs priced2025: median $0.189 per mL, 7 NDCs priced2026: median $0.182 per mL, 7 NDCs priced20192020202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per mLLowest to highestNDCs priced
2019 (2019-12-25)$0.7037
2020 (2020-12-30)$0.5598
2021 (2021-12-29)$0.60710
2022 (2022-12-28)$0.31611
2023 (2023-12-27)$0.2399
2024 (2024-12-25)$0.2298
2025 (2025-12-31)$0.1897
2026 (2026-11-11)$0.1827

Clobazam 20 MG Tablet

Generic

$1.03 per unit at the 2019 year-end survey (12 NDCs) and $0.376 at the 2026 survey (7 NDCs): −64%.

$0$1.092019: median $1.03 per unit, 12 NDCs priced2020: median $1.09 per unit, 14 NDCs priced2021: median $0.474 per unit, 13 NDCs priced2022: median $0.494 per unit, 12 NDCs priced2023: median $0.798 per unit, 10 NDCs priced2024: median $0.469 per unit, 8 NDCs priced2025: median $0.435 per unit, 8 NDCs priced2026: median $0.376 per unit, 7 NDCs priced20192020202120222023202420252026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2019 (2019-12-25)$1.0312
2020 (2020-12-30)$1.0914
2021 (2021-12-29)$0.47413
2022 (2022-12-28)$0.49412
2023 (2023-12-27)$0.79810
2024 (2024-12-25)$0.4698
2025 (2025-12-31)$0.4358
2026 (2026-11-11)$0.3767

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

Where does Clobazam sit on the generic price cliff?

Clobazam 10 MG Tablet: the first generic approval in its Orange Book group is dated 2018. Its year-end acquisition cost in 2026 is 47% of its first observed year-end price (2019). The median matched product, 8 years after its first generic approval, is at 32% (the middle half runs from 8% to 65%), so this product is inside that middle half.

0%25%50%75%100%0 years after the first generic approval: median 100%, middle half 100% to 100%, 79 products1 years after the first generic approval: median 95%, middle half 71% to 100%, 118 products2 years after the first generic approval: median 80%, middle half 49% to 99%, 135 products3 years after the first generic approval: median 64%, middle half 36% to 90%, 142 products4 years after the first generic approval: median 55%, middle half 25% to 84%, 154 products5 years after the first generic approval: median 46%, middle half 16% to 80%, 154 products6 years after the first generic approval: median 45%, middle half 16% to 87%, 154 products7 years after the first generic approval: median 40%, middle half 14% to 71%, 153 products8 years after the first generic approval: median 32%, middle half 8% to 65%, 131 products9 years after the first generic approval: median 28%, middle half 7% to 67%, 109 products10 years after the first generic approval: median 22%, middle half 5% to 53%, 90 products11 years after the first generic approval: median 21%, middle half 5% to 51%, 79 products12 years after the first generic approval: median 16%, middle half 6% to 34%, 48 products13 years after the first generic approval: median 19%, middle half 14% to 39%, 23 productsClobazam 10 MG Tablet, 1 years after the first generic approval: 100% of its first observed price, 14 NDCs pricedClobazam 10 MG Tablet, 2 years after the first generic approval: 70% of its first observed price, 16 NDCs pricedClobazam 10 MG Tablet, 3 years after the first generic approval: 58% of its first observed price, 16 NDCs pricedClobazam 10 MG Tablet, 4 years after the first generic approval: 72% of its first observed price, 14 NDCs pricedClobazam 10 MG Tablet, 5 years after the first generic approval: 69% of its first observed price, 12 NDCs pricedClobazam 10 MG Tablet, 6 years after the first generic approval: 46% of its first observed price, 10 NDCs pricedClobazam 10 MG Tablet, 7 years after the first generic approval: 50% of its first observed price, 10 NDCs pricedClobazam 10 MG Tablet, 8 years after the first generic approval: 47% of its first observed price, 9 NDCs priced024681012years since the first generic approval
median of 200 matched productsmiddle halfeach productClobazam 10 MG Tablet

This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.

How many companies make Clobazam?

The FDA Orange Book lists 10 generic makers as marketed in its largest dosage form for Clobazam, and the first generic approval is dated 22 October 2018. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Clobazam on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).